The Biden Administration announced today that the DEA will move marijuana to Schedule III. Here’s a breakdown of what that means.
In a landmark decision that marks a significant shift in federal marijuana policy, the Biden Administration announced today that the Drug Enforcement Administration (DEA) will reclassify marijuana from a Schedule I to a Schedule III controlled substance. This move will have widespread implications for both medical research and the legal landscape surrounding cannabis use.
Under the Controlled Substances Act (CSA), enacted in 1970, substances are classified into schedules based on their accepted medical use, potential for abuse, and likelihood of causing dependency. Schedule I drugs, which include LSD and heroin, are considered to have no accepted medical use and a high potential for abuse. Marijuana has been categorized under this schedule since the CSA’s enactment, a classification that has long been a point of contention among advocates, researchers, and lawmakers.
Continue reading